Serum Cardiac Troponin I concentrations in cats with anaemia - a preliminary, single-centre observational study

S M Lalor1, D A Gunn-Moore, R Cash

  • 1Division of Clinical Veterinary Sciences, Royal (Dick) School of Veterinary Studies and the Roslin Institute, The University of Edinburgh, Edinburgh.

Insights

Cats with anaemia showed higher serum cardiac troponin I concentrations, indicating potential cardiac myocyte damage. Further research is needed to confirm if anaemia causes this damage in felines.

Area of Science:

  • Veterinary Cardiology
  • Feline Medicine
  • Biomarker Research

Background:

  • Anaemia is linked to cardiovascular issues in various species.
  • The association between feline anaemia and cardiac myocyte damage is not well-established.
  • Cardiac troponin I (cTnI) is a sensitive indicator of myocardial injury.

Purpose of the Study:

  • To investigate the prevalence of cardiac myocyte damage in anaemic cats.
  • To compare serum cTnI concentrations between anaemic and non-anaemic ill cats.
  • To determine if anaemia is associated with elevated cardiac biomarkers in cats.

Main Methods:

  • Serum cTnI levels were measured in 18 anaemic cats.
  • Serum cTnI levels were measured in 31 non-anaemic ill cats with excluded primary cardiac, renal, or hematological disorders.
  • Statistical analysis compared cTnI concentrations between the two groups.

Main Results:

  • Anaemic cats exhibited significantly higher serum cTnI concentrations (0.43 ng/mL) compared to non-anaemic ill cats (0.04 ng/mL).
  • A significantly greater proportion of anaemic cats (12/18) had elevated cTnI levels above a defined threshold (0.16 ng/mL) than non-anaemic cats (7/31).

Conclusions:

  • Feline anaemia is associated with increased serum cTnI concentrations.
  • The findings suggest a potential link between anaemia and cardiac myocyte damage in cats.
  • Further investigation is warranted to elucidate the causal relationship between anaemia and elevated cTnI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
493